Secondary Ischemic Stroke Prevention

被引:28
作者
Bangad, Aaron [1 ]
Abbasi, Mehdi [1 ]
de Havenon, Adam [1 ]
机构
[1] Yale Univ, Dept Neurol, 15 York St, New Haven, CT 06510 USA
关键词
Stroke; Randomized clinical trial; Secondary stroke prevention; HEALTH-CARE PROFESSIONALS; HIGH-RISK PATIENTS; BLOOD-PRESSURE; ATRIAL-FIBRILLATION; RECURRENT STROKE; PHYSICAL-ACTIVITY; VASCULAR EVENTS; EMBOLIC STROKE; DIETARY-SODIUM; OPEN-LABEL;
D O I
10.1007/s13311-023-01352-w
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The health burden of ischemic stroke is high and will continue to increase with an aging population. Recurrent ischemic stroke is increasingly recognized as a major public health concern with potentially debilitating sequelae. Thus, it is imperative to develop and implement effective strategies for stroke prevention. When considering secondary ischemic stroke prevention, it is important to consider the mechanism of the first stroke and the related vascular risk factors. Secondary ischemic stroke prevention typically includes multiple medical and, potentially, surgical treatments, but with the shared goal of reducing the risk of recurrent ischemic stroke. Providers, health care systems, and insurers also need to consider the availability of treatments, their cost and patient burden, methods for improving adherence, and interventions that target lifestyle risk factors such as diet or activity. In this article, we discuss aspects from the 2021 AHA Guideline on Secondary Stroke Prevention as well as highlight additional information relevant to best practices for reducing recurrent stroke risk.
引用
收藏
页码:721 / 731
页数:11
相关论文
共 113 条
[1]   Results of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Trial by Stroke Subtypes [J].
Amarenco, Pierre ;
Benavente, Oscar ;
Goldstein, Larry B. ;
Callahan, Alfred, III ;
Sillesen, Henrik ;
Hennerici, Michael G. ;
Gilbert, Steve ;
Rudolph, Amy E. ;
Simunovic, Lisa ;
Zivin, Justin A. ;
Welch, K. Michael A. .
STROKE, 2009, 40 (04) :1405-1409
[2]  
Amarenco P, 2006, NEW ENGL J MED, V355, P549
[3]  
[Anonymous], 1987, LANCET, V2, P1351
[4]  
[Anonymous], 1993, Stroke, V24, P543
[5]  
Antiplatelet Trialists' Collaboration, 1994, BMJ-BRIT MED J, V308, P81, DOI [10.1136/bmj.308.6943.1540, DOI 10.1136/BMJ.308.6921.81]
[6]   Prediction of Early Recurrence After Acute Ischemic Stroke [J].
Arsava, E. Murat ;
Kim, Gyeong-Moon ;
Oliveira-Filho, Jamary ;
Gungor, Levent ;
Noh, Hyun Jin ;
Lordelo, Morgana de Jesus ;
Avery, Ross ;
Maier, Ilko L. ;
Ay, Hakan .
JAMA NEUROLOGY, 2016, 73 (04) :396-401
[7]   Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole versus clopidogrel alone or aspirin and dipyridamole in patients with acute cerebral ischaemia (TARDIS): a randomised, open-label, phase 3 superiority trial [J].
Bath, Philip M. ;
Woodhouse, Lisa J. ;
Appleton, Jason P. ;
Beridze, Maia ;
Christensen, Hanne ;
Dineen, Robert A. ;
Duley, Lelia ;
England, Timothy J. ;
Flaherty, Katie ;
Havard, Diane ;
Heptinstall, Stan ;
James, Marilyn ;
Krishnan, Kailash ;
Markus, Hugh S. ;
Montgomery, Alan A. ;
Pocock, Stuart J. ;
Randall, Marc ;
Ranta, Annemarei ;
Robinson, Thompson G. ;
Scutt, Polly ;
Venables, Graham S. ;
Sprigg, Nikola .
LANCET, 2018, 391 (10123) :850-859
[8]   Impact of the Ageing Population on the Burden of Stroke: The Dijon Stroke Registry [J].
Bejot, Yannick ;
Bailly, Henri ;
Graber, Mathilde ;
Garnier, Lucie ;
Laville, Annabel ;
Dubourget, Lucile ;
Mielle, Nathalie ;
Chevalier, Corinne ;
Durier, Jerome ;
Giroud, Maurice .
NEUROEPIDEMIOLOGY, 2019, 52 (1-2) :78-85
[9]  
Benavente OR, 2013, LANCET, V382, P506
[10]   Effects of Clopidogrel Added to Aspirin in Patients with Recent Lacunar Stroke [J].
Benavente, Oscar R. ;
Hart, Robert G. ;
McClure, Leslie A. ;
Szychowski, Jeffrey M. ;
Coffey, Christopher S. ;
Pearce, Lesly A. .
NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (09) :817-825